基于染色体不稳定性的分子亚型和预后特征的识别与肺腺癌的表型相关的基因
Youngsic Jeon1, Kyung-Chul Choi2, Young Nyun Park3
1Institute of Natural Products, Korea Institute of Science and Technology, Gangneung 25451, Republic of Korea.
Cancers
|November 27, 2024
概括
这项研究基于染色体不稳定性 (CIN) 基因确定了肺腺癌 (LUAD) 中不同的分子亚型. 高CIN组的生存率很低,突出显示了CIN基因状态作为LUAD的关键预后标志物.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 肺腺癌 (LUAD) 具有显著的分子异质性,需要精细分类以改善患者的治疗结果.
- 之前的研究还没有完全阐明LUAD中独特的分子亚型.
- 了解LUAD的分子驱动因素对于开发向疗法至关重要.
研究的目的:
- 根据染色体不稳定性 (CIN) 表型基因将肺腺癌 (LUAD) 分类为不同的分子亚型.
- 评估LUAD中CIN表型基因状态的预后价值.
- 探索CIN亚型与基因组改变之间的关联.
主要方法:
- 使用TCGA-LUAD队列 (n=592) 识别了24个LUAD显著的CIN表型基因.
- 无监督的集群和主要成分分析将LUAD患者分类为与CIN相关的亚型 (低组,中组,高组).
- 单变量和多变量分析,生存分析 (OS,DFS) 和基因组分析 (突变,拷贝数变化).
主要成果:
- LUAD患者被分为三个CIN表型相关的亚型,具有不同的转录组图案.
- 高组的总体存活率 (OS) 和无病存活率 (DFS) 显着较差.
- CIN表型基因状态是一个独立的预后预测因素,表现优于病理等级,并与特定的基因突变 (KEAP1,LYST,SETD2,TP53) 和副本数量的增加有关.
结论:
- CIN表型基因状态是LUAD的关键预后标志物,独立于病理等级.
- 由CIN基因定义的LUAD亚型显示出不同的转录和基因组概况.
- 这些发现支持进一步的临床验证和针对LUAD中CIN途径的潜在治疗策略.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K